Breadcrumb

CRP  |  Cancer Research Program

CRP News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Four RI-MUHC grad students land top federal funding

Four graduate students from the Research Institute of the McGill University Health Centre (RI-MUHC) are among the 16 from McGill to win 2019 Vanier Scholarships.

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

What’s new at the 2019 Cancer Research Program (CRP) Research Day?

Along with traditional presentations, the first CRP 3-minute thesis competition!

Predicting Breast Cancer Metastasis to the Lung and Liver with Biomarkers

RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung

Rising to the 3-Minute Thesis challenge

Zeinab Sharifi, doctoral student at the RI-MUHC, advances to the regional level with her first-prize placement at McGill

Three RI-MUHC teams receive funding from the CFI and Government of Quebec

Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago

Focus on McGill Nursing Faculty: Christine Maheu shares her passion for cancer survivorship care and research

“My research is focused on programs to help cancer survivors cope with uncertainty and fear of recurrence along with support in the return to work”

RI-MUHC Team Wins Québec Science's 2018 People's Choice Award for Discovery of the Year

A reliable test for early detection of endometrial and ovarian cancers wins Québec Science’s 2018 Award for Discovery of the Year!

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer

Explore news and events at the RI-MUHC